Skip to main content

We need more new antibiotics

By Helen Boucher, Special to CNN
updated 6:43 PM EDT, Thu June 13, 2013
STORY HIGHLIGHTS
  • Obama administration is considering streamlining the approval process for antibiotics
  • Helen Boucher: For patients with life-threatening infections, access to new antibiotics is vital
  • She says by limiting their use to the sickest of the sick, we can minimize risks of new drugs
  • Boucher: We need to encourage more companies to do antibiotic research and development

Editor's note: Helen Boucher is director of the infectious diseases fellowship program and staff physician at Tufts Medical Center, and associate professor of medicine at Tufts University School of Medicine. She is a member of the Infectious Diseases Society of America's Antimicrobial Resistance Committee and serves in advisory roles related to antibiotic development for some pharmaceutical companies.

(CNN) -- For desperately ill patients with serious, life-threatening antibiotic-resistant infections, access to new antibiotics is a matter of life and death.

All across America, people are dying from bacterial infections that we used to be able to cure with antibiotics.

Just this March, the Centers for Disease Control and Prevention warned the public about a four-fold increase in one group of "nightmare bacteria," carbapenem-resistant Enterobacteriaceae, which kills up to 50% of the people infected, and is on the rise. The annual impact of antibiotic resistant infections on the U.S. health care system is estimated to be $21 billion to $34 billion in excess health care costs and more than 8 million additional hospital days. At the same time, we are not making new antibiotics fast enough to prevent these deaths.

Without new antibiotics, things we all take for granted, including surgery, chemotherapy, organ transplantation and premature infant care, will be in jeopardy. A streamlined but targeted approach that speeds regulatory approval of new antibiotics -- and limits their use to the sickest of the sick -- is an appropriate way to balance the safety risks of these new drugs with the lifesaving benefits they can offer patients who have no other treatment options.

Helen Boucher
Helen Boucher

As a practicing infectious disease physician, my colleagues and I are seeing firsthand the devastating effects that resistant infections have on patients.

Consider Addie Rerecich, who was a healthy, athletic 11-year-old in 2011 before she spent five months in an Arizona hospital battling several serious drug-resistant infections that her doctors did not have antibiotics powerful enough to treat. Addie ultimately needed a double lung transplant to save her life. The health care costs from her hospital stay alone totaled $6 million, and she will need medical attention and therapy for the rest of her life.

As resistant infections like those that nearly took Addie's life continue to increase, the antibiotic pipeline is nearly dry, with few drugs in development that will work against the most alarming pathogens our patients face.

A proposal from the Infectious Diseases Society of America aims to address a key part of the problem by reducing the obstacles to regulatory approval of new antibiotics for use in a distinct, narrow group of people: Patients with serious resistant infections that have no effective treatment options left.

How will this make a difference?

The current regulatory environment in the U.S. discourages drug companies from antibiotic research and development, and few firms are active in this area today. Antibiotics also aren't as profitable as other drugs, such as those for chronic conditions like heart disease or diabetes, which patients often take for years. A more direct path for regulatory approval can encourage more companies to get involved in antibiotic development again.

IDSA's approach -- the Limited Population Antibacterial Drug -- would speed patients' access to new, lifesaving antibiotics by allowing the Food and Drug Administration to approve them for narrow use based on smaller clinical trials than required for more widely used antibiotics. Under LPAD, drug companies will still have to show that a drug's benefits outweigh the risks in patients with serious infections. It's an idea modeled after the successful Orphan Drug Program, which encourages the development of drugs for rare diseases.

Promoting the appropriate use of these new antibiotics is critical, because we know antibiotic misuse and overuse are significant drivers of drug resistance.

Special labeling will ensure narrow marketing of these drugs. Educational efforts should be put in place to send a strong signal to health care providers, facilities and insurers that these drugs are only for patients who need them most. These drugs will also likely be priced higher, commensurate with their value as life-saving medicines, than traditionally approved antibiotics, another factor that will help limit their wider use.

Antibiotic stewardship programs, which encourage appropriate antibiotic use by providers and health facilities, will play a key role. These programs provide much needed support and guidance to clinicians and ensure that our precious resource of antibiotics will be used wisely.

Professional medical groups -- including the American Medical Association -- public health organizations, patient groups and pharmaceutical manufacturers have voiced their support for IDSA's proposal. FDA and several members of Congress are also interested in the concept and in moving it forward.

To be sure, developing new antibiotics and speeding their approval process to treat seriously ill patients is just one way to grapple with this complex public health crisis.

IDSA also promotes enhanced public health efforts, including better data collection and surveillance of drug resistance and the use of antibiotics, improved infection prevention, antimicrobial stewardship, and stronger efforts to encourage the appropriate use of antibiotics in humans and on the farm. Increased research funding to explore how antibiotic resistance develops and spreads is just as vital, along with additional economic incentives and regulatory clarity to boost antibiotic development.

Patients like Addie need our help. We must take action now.

Follow @CNNOpinion on Twitter.

Join us at Facebook/CNNOpinion.

The opinions expressed in this commentary are solely those of Helen Boucher.

ADVERTISEMENT
Part of complete coverage on
updated 5:01 PM EDT, Wed October 22, 2014
Paul Callan says the grand jury is the right process to use to decide if charges should be brought against the police officer
updated 12:19 PM EDT, Thu October 23, 2014
Theresa Brown says the Ebola crisis brought nurses into the national conversation on health care. They need to stay there.
updated 6:35 PM EDT, Tue October 21, 2014
Patrick Hornbeck says don't buy the hype: The arguments the Vatican used in its interim report would have virtually guaranteed that same-sex couples remained second class citizens
updated 9:36 AM EDT, Fri October 24, 2014
Paul Begala says Iowa's U.S. Senate candidate, Joni Ernst, told NRA she has right to use gun to defend herself--even from the government. But shooting at officials is not what the Founders had in mind
updated 6:08 PM EDT, Thu October 23, 2014
John Sutter: Why are we so surprised the head of a major international corporation learned another language?
updated 5:54 PM EDT, Thu October 23, 2014
Jason Johnson says Ferguson isn't a downtrodden community rising up against the white oppressor, but it is looking for justice
updated 12:21 PM EDT, Fri October 24, 2014
Sally Kohn says a video of little girls dressed as princesses using the F-word very loudly to condemn sexism is provocative. But is it exploitative?
updated 4:06 PM EDT, Tue October 21, 2014
Timothy Stanley says Lewinsky is shamelessly playing the victim in her affair with Bill Clinton, humiliating Hillary Clinton again and aiding her critics
updated 10:14 AM EDT, Thu October 23, 2014
Imagine being rescued from modern slavery, only to be charged with a crime, writes John Sutter
updated 12:00 PM EDT, Tue October 21, 2014
Tidal flooding used to be a relatively rare occurrence along the East Coast. Not anymore, write Melanie Fitzpatrick and Erika Spanger-Siegfried.
updated 7:35 AM EDT, Tue October 21, 2014
Carol Costello says activists, writers, politicians have begun discussing their abortions. But will that new approach make a difference on an old battleground?
updated 9:12 AM EDT, Tue October 21, 2014
Sigrid Fry-Revere says the National Organ Transplant Act has caused more Americans to die waiting for an organ than died in both World Wars, Korea, Vietnam, Afghanistan and Iraq
updated 2:51 PM EDT, Tue October 21, 2014
Crystal Wright says racist remarks like those made by black Republican actress Stacey Dash do nothing to get blacks to join the GOP
updated 6:07 PM EDT, Tue October 21, 2014
Mel Robbins says by telling her story, Monica Lewinsky offers a lesson in confronting humiliating mistakes while keeping her head held high
updated 9:29 AM EDT, Mon October 20, 2014
Cornell Belcher says the story of the "tea party wave" in 2010 was bogus; it was an election determined by ebbing Democratic turnout
updated 4:12 PM EDT, Mon October 20, 2014
Les Abend says pilots want protocols, preparation and checklists for all contingencies; at the moment, controlling a deadly disease is out of their comfort zone
updated 11:36 PM EDT, Sun October 19, 2014
David Weinberger says an online controversy that snowballed from a misogynist attack by gamers into a culture war is a preview of the way news is handled in a world of hashtag-fueled scandal
updated 8:23 AM EDT, Mon October 20, 2014
Julian Zelizer says Paul Krugman makes some good points in his defense of President Obama but is premature in calling him one of the most successful presidents.
updated 10:21 PM EDT, Sun October 19, 2014
Conservatives can't bash and slash government and then suddenly act surprised if government isn't there when we need it, writes Sally Kohn
updated 8:05 AM EDT, Wed October 22, 2014
ISIS is looking to take over a good chunk of the Middle East -- if not the entire Muslim world, write Peter Bergen and Emily Schneider.
updated 9:00 AM EDT, Mon October 20, 2014
The world's response to Ebola is its own sort of tragedy, writes John Sutter
updated 4:33 PM EDT, Fri October 17, 2014
Hidden away in Russian orphanages are thousands of children with disabilities who aren't orphans, whose harmful treatment has long been hidden from public view, writes Andrea Mazzarino
updated 1:22 PM EDT, Sat October 18, 2014
When you hear "trick or treat" this year, think "nudge," writes John Bare
updated 12:42 AM EDT, Sat October 18, 2014
The more than 200 kidnapped Nigerian schoolgirls have become pawns in a larger drama, writes Richard Joseph.
updated 9:45 AM EDT, Fri October 17, 2014
Peggy Drexler said Amal Alamuddin was accused of buying into the patriarchy when she changed her name to Clooney. But that was her choice.
updated 4:43 PM EDT, Thu October 16, 2014
Ford Vox says the CDC's Thomas Frieden is a good man with a stellar resume who has shown he lacks the unique talents and vision needed to confront the Ebola crisis
updated 4:58 AM EDT, Sat October 18, 2014
How can such a numerically small force as ISIS take control of vast swathes of Syria and Iraq?
updated 9:42 AM EDT, Fri October 17, 2014
How big a threat do foreign fighters in Syria and Iraq pose to the West? It's a question that has been much on the mind of policymakers and commentators.
updated 8:21 AM EDT, Fri October 17, 2014
More than a quarter-million American women served honorably in the Iraq and Afghanistan wars. Now they are home, we have an obligation to help them transition back to civilian life.
updated 4:27 PM EDT, Thu October 16, 2014
Paul Begala says Rick Scott's deeply weird refusal to begin a debate because rival Charlie Crist had a fan under his podium spells disaster for the Florida governor--delighting Crist
updated 12:07 AM EDT, Thu October 16, 2014
The longer we wait to engage on Ebola, the more limited our options will become, says Marco Rubio.
updated 7:53 AM EDT, Wed October 15, 2014
Democratic candidates who run from President Obama in red states where he is unpopular are making a big mistake, says Donna Brazile
updated 12:29 AM EDT, Thu October 16, 2014
At some 7 billion people, the world can sometimes seem like a crowded place. But if the latest estimates are to be believed, then in less than a century it is going to feel even more so -- about 50% more crowded, says Evan Fraser
updated 12:53 PM EDT, Mon October 20, 2014
Paul Callan says the Ebola situation is pointing up the need for better leadership
updated 6:45 PM EDT, Wed October 15, 2014
Nurses are the unsung heroes of the Ebola outbreak. Yet, there are troubling signs we're failing them, says John Sutter
updated 1:00 PM EDT, Wed October 15, 2014
Dean Obeidallah says it's a mistake to give up a business name you've invested energy in, just because of a new terrorist group
updated 7:01 PM EDT, Wed October 15, 2014
Fear of Ebola is contagious, writes Mel Robbins; but it's time to put the disease in perspective
updated 1:44 PM EDT, Tue October 14, 2014
Oliver Kershaw says that if Big Tobacco is given monopoly of e-cigarette products, public health will suffer.
updated 9:35 AM EDT, Sat October 18, 2014
Stop thinking your job will make you happy.
updated 10:08 PM EDT, Tue October 14, 2014
Ruben Navarrette says it's time to deal with another scandal involving the Secret Service — one that leads directly into the White House.
updated 7:25 AM EDT, Tue October 14, 2014
Americans who choose to fight for militant groups or support them are young and likely to be active in jihadist social media, says Peter Bergen
updated 9:03 AM EDT, Mon October 13, 2014
Stephanie Coontz says 11 years ago only one state allowed same sex marriage. Soon, some 60% of Americans will live where gays can marry. How did attitudes change so quickly?
updated 4:04 PM EDT, Tue October 14, 2014
Legalizing assisted suicide seems acceptable when focusing on individuals. But such laws would put many at risk of immense harm, writes Marilyn Golden.
updated 9:07 AM EDT, Mon October 13, 2014
Julian Zelizer says the issues are huge, but both parties are wrestling with problems that alienate voters
updated 6:50 PM EDT, Mon October 13, 2014
Mel Robbins says the town's school chief was right to cancel the season, but that's just the beginning of what needs to be done
updated 11:43 AM EDT, Sat October 11, 2014
He didn't discover that the world was round, David Perry writes. So what did he do?
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT